| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000250734.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.00221232 |
Resistant |
| ENSG00000250734.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043739586 |
Resistant |
| ENSG00000250734.2 |
Ponatinib |
Brain lower grade glioma |
0.01287204 |
Resistant |
| ENSG00000250734.2 |
Ponatinib |
Sarcoma |
0.041219271 |
Resistant |
